{"id":4853,"date":"2020-07-03T14:24:48","date_gmt":"2020-07-03T17:24:48","guid":{"rendered":"https:\/\/phelcom.com\/?p=4853"},"modified":"2023-06-01T17:31:57","modified_gmt":"2023-06-01T20:31:57","slug":"coronavirus-vacina-para-cegueira","status":"publish","type":"post","link":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/","title":{"rendered":"Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira"},"content":{"rendered":"<p>De fato, o mundo inteiro est\u00e1 correndo para encontrar uma vacina contra a Covid-19. Renomadas universidades, institutos de pesquisas e diversas organiza\u00e7\u00f5es de sa\u00fade trabalham incansavelmente, em diferentes vertentes, para desenvolver a prote\u00e7\u00e3o para o novo coronav\u00edrus (SARS-CoV-2), respons\u00e1vel pela morte de mais de 500 mil pessoas em todo o planeta.<\/p>\n<p>Um desses projetos \u00e9 o programa de vacinas AAVCOVID, baseado em uma\u00a0terapia g\u00eanica utilizada para tratamento de distrofia da retina heredit\u00e1ria &#8211; problema que provoca a perda de vis\u00e3o. Como a tecnologia j\u00e1 \u00e9 aprovada e devido \u00e0 urg\u00eancia frente a atual pandemia, a vacina poderia entrar no mercado em quest\u00e3o de semanas, por exemplo.<\/p>\n<p>Em seguida, entenda mais sobre esse estudo liderado pelos Estados Unidos e quais ser\u00e3o os pr\u00f3ximos passos.<\/p>\n<h2>A pesquisa<\/h2>\n<p>Desenvolvido por dois institutos ligados ao Hospital Geral de Massachusetts, em Boston (EUA), o <a href=\"https:\/\/www.novartis.com.br\/programa-de-vacinas-aavcovid-assina-contrato-de-fabricacao-com-avexis-empresa-do-grupo-novartis\">programa de vacina AAVCOVID<\/a> \u00e9 baseado em uma terapia g\u00eanica j\u00e1 aprovada no tratamento de distrofia da retina heredit\u00e1ria e de atrofia muscular espinhal.<\/p>\n<p>Essa tecnologia utiliza o adenov\u00edrus associado (AAV), testado por mais de duas d\u00e9cadas e comprovadamente seguro para os seres humanos. Al\u00e9m disso, \u00e9 adapt\u00e1vel a diferentes subst\u00e2ncias e alcan\u00e7a resposta imune satisfat\u00f3ria.<\/p>\n<p>Contra o novo coronav\u00edrus, a ideia \u00e9 usar um vetor AAV para fornecer sequ\u00eancias gen\u00e9ticas do SARS-CoV-2. Desse modo, a vacina\u00e7\u00e3o entrega fragmentos de DNA gen\u00e9tico do v\u00edrus, que gera uma prote\u00edna antig\u00eanica, projetada para provocar uma resposta imune para prevenir a infec\u00e7\u00e3o.<\/p>\n<p>Ou seja, o AAV fornecer\u00e1 instru\u00e7\u00f5es para a produ\u00e7\u00e3o da chamada prote\u00edna &#8216;spike&#8217;, que auxilia a entrada e a replica\u00e7\u00e3o do coronav\u00edrus na c\u00e9lula. Assim, o sistema imunol\u00f3gico reconhecer\u00e1 como agente externo e produzir\u00e1 anticorpos espec\u00edficos para combater a doen\u00e7a.<\/p>\n<p>Mesmo se o coronav\u00edrus sofrer muta\u00e7\u00e3o e surgir uma nova cepa, as instru\u00e7\u00f5es gen\u00e9ticas poder\u00e3o ser trocadas. Dessa forma, produzir uma vacina atualizada e em apenas algumas semanas.<\/p>\n<h2>Pr\u00f3ximos passos<\/h2>\n<p>At\u00e9 o momento, os testes foram realizados apenas em camundongos. Em breve, os experimentos ser\u00e3o feitos em primatas. A expectativa \u00e9 que at\u00e9 o fim do ano o estudo avance para avalia\u00e7\u00f5es em humanos.<\/p>\n<p>Segundo os pesquisadores, duas vers\u00f5es da vacina \u2013 do total de sete &#8211; j\u00e1 est\u00e3o sendo fabricadas para estudos cl\u00ednicos.<\/p>\n<h2>Conclus\u00e3o<\/h2>\n<p>Sem d\u00favida, a vacina experimental baseada em uma tecnologia j\u00e1 existente de terapia g\u00eanica com adenov\u00edrus associado (AAV) \u00e9 uma grande vantagem. Isso porque, se comprovada a sua efic\u00e1cia, a produ\u00e7\u00e3o de bilh\u00f5es de doses pode ser feita em semanas devido a situa\u00e7\u00e3o emergencial.<\/p>\n<p>Por outro lado, ainda \u00e9 imprescind\u00edvel mais testes cl\u00ednicos para garantir a seguran\u00e7a e efetividade da nova vacina.<\/p>\n<p>Acompanhe as novidades sobre coronav\u00edrus e olhos no blog da Phelcom.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Saiba mais sobre o programa de vacinas AAVCOVID. <\/p>\n","protected":false},"author":3,"featured_media":4854,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[104],"tags":[],"class_list":["post-4853","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-inovacao"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira - PHELCOM Technologies<\/title>\n<meta name=\"description\" content=\"O programa de vacinas contra o coronav\u00edrus &quot;AAVCOVID&quot; \u00e9 baseado em uma\u00a0terapia g\u00eanica utilizada para tratamento de distrofia da retina heredit\u00e1ria.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira - PHELCOM Technologies\" \/>\n<meta property=\"og:description\" content=\"O programa de vacinas contra o coronav\u00edrus &quot;AAVCOVID&quot; \u00e9 baseado em uma\u00a0terapia g\u00eanica utilizada para tratamento de distrofia da retina heredit\u00e1ria.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/\" \/>\n<meta property=\"og:site_name\" content=\"PHELCOM Technologies\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/phelcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-03T17:24:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-01T20:31:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/phelcom.com\/wp-content\/uploads\/2020\/07\/vacina-coronav\u00edrus.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"555\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gabriela Marques\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gabriela Marques\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/\"},\"author\":{\"name\":\"Gabriela Marques\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/person\\\/4e0e58359256b5df6d71d632d2fbdd20\"},\"headline\":\"Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira\",\"datePublished\":\"2020-07-03T17:24:48+00:00\",\"dateModified\":\"2023-06-01T20:31:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/\"},\"wordCount\":499,\"publisher\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/vacina-coronav\u00edrus.jpg\",\"articleSection\":[\"Inova\u00e7\u00e3o\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/\",\"url\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/\",\"name\":\"Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira - PHELCOM Technologies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/vacina-coronav\u00edrus.jpg\",\"datePublished\":\"2020-07-03T17:24:48+00:00\",\"dateModified\":\"2023-06-01T20:31:57+00:00\",\"description\":\"O programa de vacinas contra o coronav\u00edrus \\\"AAVCOVID\\\" \u00e9 baseado em uma\u00a0terapia g\u00eanica utilizada para tratamento de distrofia da retina heredit\u00e1ria.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/#primaryimage\",\"url\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/vacina-coronav\u00edrus.jpg\",\"contentUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/vacina-coronav\u00edrus.jpg\",\"width\":1080,\"height\":555,\"caption\":\"coronav\u00edrus\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/inovacao\\\/coronavirus-vacina-para-cegueira\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/\",\"name\":\"PHELCOM Technologies\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#organization\",\"name\":\"Phelcom\",\"url\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2018\\\/07\\\/color_horizontal.png\",\"contentUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2018\\\/07\\\/color_horizontal.png\",\"width\":245,\"height\":40,\"caption\":\"Phelcom\"},\"image\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/phelcom\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/phelcom-technologies\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCSZCLEV9ZrbGBie0R0IxQpA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/person\\\/4e0e58359256b5df6d71d632d2fbdd20\",\"name\":\"Gabriela Marques\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira - PHELCOM Technologies","description":"O programa de vacinas contra o coronav\u00edrus \"AAVCOVID\" \u00e9 baseado em uma\u00a0terapia g\u00eanica utilizada para tratamento de distrofia da retina heredit\u00e1ria.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/","og_locale":"pt_BR","og_type":"article","og_title":"Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira - PHELCOM Technologies","og_description":"O programa de vacinas contra o coronav\u00edrus \"AAVCOVID\" \u00e9 baseado em uma\u00a0terapia g\u00eanica utilizada para tratamento de distrofia da retina heredit\u00e1ria.","og_url":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/","og_site_name":"PHELCOM Technologies","article_publisher":"https:\/\/www.facebook.com\/phelcom\/","article_published_time":"2020-07-03T17:24:48+00:00","article_modified_time":"2023-06-01T20:31:57+00:00","og_image":[{"width":1080,"height":555,"url":"https:\/\/phelcom.com\/wp-content\/uploads\/2020\/07\/vacina-coronav\u00edrus.jpg","type":"image\/jpeg"}],"author":"Gabriela Marques","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Gabriela Marques","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/#article","isPartOf":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/"},"author":{"name":"Gabriela Marques","@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/person\/4e0e58359256b5df6d71d632d2fbdd20"},"headline":"Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira","datePublished":"2020-07-03T17:24:48+00:00","dateModified":"2023-06-01T20:31:57+00:00","mainEntityOfPage":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/"},"wordCount":499,"publisher":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#organization"},"image":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/#primaryimage"},"thumbnailUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2020\/07\/vacina-coronav\u00edrus.jpg","articleSection":["Inova\u00e7\u00e3o"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/","url":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/","name":"Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira - PHELCOM Technologies","isPartOf":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/#primaryimage"},"image":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/#primaryimage"},"thumbnailUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2020\/07\/vacina-coronav\u00edrus.jpg","datePublished":"2020-07-03T17:24:48+00:00","dateModified":"2023-06-01T20:31:57+00:00","description":"O programa de vacinas contra o coronav\u00edrus \"AAVCOVID\" \u00e9 baseado em uma\u00a0terapia g\u00eanica utilizada para tratamento de distrofia da retina heredit\u00e1ria.","breadcrumb":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/#primaryimage","url":"https:\/\/phelcom.com\/wp-content\/uploads\/2020\/07\/vacina-coronav\u00edrus.jpg","contentUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2020\/07\/vacina-coronav\u00edrus.jpg","width":1080,"height":555,"caption":"coronav\u00edrus"},{"@type":"BreadcrumbList","@id":"https:\/\/phelcom.com\/pt-br\/blog\/inovacao\/coronavirus-vacina-para-cegueira\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/phelcom.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Coronav\u00edrus: vacina experimental \u00e9 baseada em terapia gen\u00e9tica para cegueira"}]},{"@type":"WebSite","@id":"https:\/\/phelcom.com\/pt-br\/en\/#website","url":"https:\/\/phelcom.com\/pt-br\/en\/","name":"PHELCOM Technologies","description":"","publisher":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/phelcom.com\/pt-br\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/phelcom.com\/pt-br\/en\/#organization","name":"Phelcom","url":"https:\/\/phelcom.com\/pt-br\/en\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/logo\/image\/","url":"https:\/\/phelcom.com\/wp-content\/uploads\/2018\/07\/color_horizontal.png","contentUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2018\/07\/color_horizontal.png","width":245,"height":40,"caption":"Phelcom"},"image":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/phelcom\/","https:\/\/www.linkedin.com\/company\/phelcom-technologies","https:\/\/www.youtube.com\/channel\/UCSZCLEV9ZrbGBie0R0IxQpA"]},{"@type":"Person","@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/person\/4e0e58359256b5df6d71d632d2fbdd20","name":"Gabriela Marques"}]}},"_links":{"self":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/posts\/4853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/comments?post=4853"}],"version-history":[{"count":0,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/posts\/4853\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/media\/4854"}],"wp:attachment":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/media?parent=4853"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/categories?post=4853"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/tags?post=4853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}